iqvia semaglutide tirzepatide prescriptions us q3 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA's Update Weight Loss Dynamics and Health

We performed this subgroup analysis for two reasons: 1) to eliminate the potentially confounding factor of using other diabetic medications such as metformin or insulin, and 2) we did not have data on the severity of diabetes such as hemoglobin A1c which may be an additional confounding factor

Palombo et al

More GLP-1 Resources I have other resources related to using a GLP-1 and my personal journey that you might like

Accessed 2 Sep 2023 Shamriz O, NaserEddin A, Mosenzon O, Sviri S, Tal Y (2019) Allergic reaction to exenatide and lixisenatide but not to liraglutide: unveiling anaphylaxis to glucagon-like peptide 1 receptor agonists

Proteins were transferred onto nitrocellulose membranes using a wet transfer apparatus (Bio-Rad) at 100 V for 1 h